Ongoing (Closed To New Participants)

• Expanded Access Protocol for Boys with Duchenne Muscular Dystrophy

  Brief Description: For details, please refer to https://www.clinicaltrials.gov/ct2/show/NCT03863119
  Sponsor: Santhera Pharmaceuticals (Switzerland) Ltd. (Formerly ReveraGen)